Nicola Magrini, the new head of the Italian Medicines Agency, AIFA, is a high-profile drug price transparency advocate, which suggests that he will continue to work on the issue, just as his predecessor did.
Magrini’s background points in that direction and observers note that he is committed to public health, medicines access and fair and transparent pricing
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?